AXGN Axogen Inc.

Axogen, Inc. to Report Third Quarter 2020 Financial Results and Host Conference Call on October 29, 2020

Axogen, Inc. to Report Third Quarter 2020 Financial Results and Host Conference Call on October 29, 2020
EN
08/10/2020

Underlying

AXGNAxogen Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Axogen Inc.

 PRESS RELEASE
Free
AXGN AXOGEN INC.

Axogen, Inc. Reports Second Quarter 2025 Financial Results

Axogen, Inc. Reports Second Quarter 2025 Financial Results Raises Full Year Revenue Guidance to at Least 17% Growth or $219 Million ALACHUA, Fla. and TAMPA, Fla., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today reported financial results and business highlights for the second quarter ended June 30, 2025. Second Quarter Financial Results Second quarter revenue was $56.7 million, an 18.3% increase compared to the second quarter of 2024,...

August 5, 2025 1 EN
 PRESS RELEASE
Free
AXGN AXOGEN INC.

Axogen, Inc. to participate at the Canaccord Genuity 45th Annual Growt...

Axogen, Inc. to participate at the Canaccord Genuity 45th Annual Growth Conference ALACHUA, Fla. and TAMPA, Fla., July 29, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that management will be available for one-on-one investor meetings at the Canaccord Genuity 45th Annual Growth Conference on Tuesday, August 12, 2025. About Axogen Axogen (AXGN) is the leading Company focused specifically on the science, development, and commercialization of ...

July 29, 2025 1 EN
 PRESS RELEASE
Free
AXGN AXOGEN INC.

Axogen, Inc. to report 2025 second quarter financial results on August...

Axogen, Inc. to report 2025 second quarter financial results on August 5, 2025 ALACHUA, Fla. and TAMPA, Fla., July 22, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that it will report 2025 second quarter financial results on Tuesday, August 5, 2025, before the market opens. Axogen management will host an investment-community conference call and webcast at 8 a.m. ET following the release. Investors interested in participating in the conferenc...

July 22, 2025 1 EN
 PRESS RELEASE
Free
AXGN AXOGEN INC.

Axogen, Inc to Participate at Goldman Sachs Global Healthcare Conferen...

Axogen, Inc to Participate at Goldman Sachs Global Healthcare Conference ALACHUA, Fla. and TAMPA, Fla., May 28, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Michael Dale, board director, chief executive officer, and president, will participate in a fireside chat at the Goldman Sachs Global Healthcare Conference, on Wednesday, June 11, 2025, at 2:00 p.m. ET. Webcast events can be accessed live through the  page at . For those not available to listen to the...

May 28, 2025 1 EN
 PRESS RELEASE
Free
AXGN AXOGEN INC.

Axogen, Inc. Reports 2025 First Quarter Financial Results

Axogen, Inc. Reports 2025 First Quarter Financial Results ALACHUA, Fla. and TAMPA, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and business highlights for the first quarter ended March 31, 2025. First Quarter Financial Results First quarter revenue was $48.6 million, a 17.4% increase compared to the first quarter of 2024.For the first quarter of 2025, gross margin was 71.9%, down from 78.8% for the first quarter of 2024.Net los...

May 8, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch